Species Differences between Mouse and Human PPARα in Modulating the Hepatocarcinogenic Effects of Perinatal Exposure to a High-Affinity Human PPARα Agonist in Mice

Species Differences between Mouse and Human PPARα in Modulating the Hepatocarcinogenic Effects of Perinatal Exposure to a High-Affinity Human PPARα Agonist in Mice

(2021) Jennifer E Foreman et al.   TOXICOLOGICAL SCIENCES

Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma

(2020) Tatsuo Kanda et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Human relevance of rodent liver tumors: Key insights from a Toxicology Forum workshop on nongenotoxic modes of action

(2018) Susan P. Felter et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

Editor’s Highlight: PPARβ/δ and PPARγ Inhibit Melanoma Tumorigenicity by Modulating Inflammation and Apoptosis

(2017) Michael G. Borland et al.   TOXICOLOGICAL SCIENCES

Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy

(2016) Takayuki Koga et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Editor’s Highlight: Perfluorooctane Sulfonate-Choline Ion Pair Formation: A Potential Mechanism Modulating Hepatic Steatosis and Oxidative Stress in Mice

(2016) Limin Zhang et al.   TOXICOLOGICAL SCIENCES

Adverse drug reactions in neonates and infants: a population-tailored approach is needed

(2015) Karel Allegaert et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Dose-Dependent Incidence of Hepatic Tumors in Adult Mice following Perinatal Exposure to Bisphenol A

(2014) Caren Weinhouse et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

Activation of Peroxisome Proliferator-Activated Receptor- /  (PPAR- / ) Inhibits Human Breast Cancer Cell Line Tumorigenicity

(2014) P.-L. Yao et al.   MOLECULAR CANCER THERAPEUTICS

Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study

(2013) J. Christopher Corton et al.   CRITICAL REVIEWS IN TOXICOLOGY

Perinatal Exposure to Oestradiol and Bisphenol A Alters the Prostate Epigenome and Increases Susceptibility to Carcinogenesis

(2010) Gail S. Prins et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Hepatic Enzyme Induction

(2010) Robert R. Maronpot et al.   TOXICOLOGIC PATHOLOGY

Proliferative and Nonproliferative Lesions of the Rat and Mouse Hepatobiliary System

(2010) Bob Thoolen et al.   TOXICOLOGIC PATHOLOGY

A Reexamination of the PPAR-α Activation Mode of Action as a Basis for Assessing Human Cancer Risks of Environmental Contaminants

(2009) Kathryn Z. Guyton et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

Reproductive and Developmental Toxicity of Phthalates

(2009) Jan L. Lyche et al.   JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS

Impact of genetic and epigenetic factors from early life to later disease

(2008) Johanne Tremblay et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

If nicotine is a developmental neurotoxicant in animal studies, dare we recommend nicotine replacement therapy in pregnant women and adolescents?

(2008) Theodore A. Slotkin   NEUROTOXICOLOGY AND TERATOLOGY

A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States — II) Untreated drinking water sources

(2008) Michael J. Focazio et al.   SCIENCE OF THE TOTAL ENVIRONMENT

A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States — I) Groundwater

(2008) Kimberlee K. Barnes et al.   SCIENCE OF THE TOTAL ENVIRONMENT

Mechanistic Evaluation of PPARα-Mediated Hepatocarcinogenesis: Are We There Yet?

(2007) Jeffrey M. Peters   TOXICOLOGICAL SCIENCES